BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+28.43%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$15.2B
AUM Growth
+$15.2B
Cap. Flow
-$49.8M
Cap. Flow %
-0.33%
Top 10 Hldgs %
84.66%
Holding
127
New
12
Increased
13
Reduced
22
Closed
28

Top Buys

1
AMRN
Amarin Corp
AMRN
$185M
2
PRNB
Principia Biopharma Inc. Common Stock
PRNB
$52.2M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
$25.1M
4
INSM icon
Insmed
INSM
$23.3M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$12.9M

Top Sells

1
BLUE
bluebird bio
BLUE
$20.5M
2
PHXM
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$17.1M
3
HALO icon
Halozyme
HALO
$15.2M
4
EXEL icon
Exelixis
EXEL
$11M
5
XNCR icon
Xencor
XNCR
$10.5M

Sector Composition

1 Healthcare 91.43%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BLUE
51
DELISTED
bluebird bio
BLUE
$8.68M 0.06%
59,441
-140,559
-70% -$20.5M
ALBO
52
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$8.24M 0.05%
250,000
– –
HALO icon
53
Halozyme
HALO
$8.75B
$8.18M 0.05%
449,969
-833,960
-65% -$15.2M
MNTA
54
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$8.11M 0.05%
308,500
– –
VKTX icon
55
Viking Therapeutics
VKTX
$3.02B
$7.4M 0.05%
+425,000
New +$7.4M
FSTX
56
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$7.39M 0.05%
613,144
+240,000
+64% +$2.89M
AUTL
57
Autolus Therapeutics
AUTL
$383M
$7.22M 0.05%
235,294
– –
VYNE icon
58
VYNE Therapeutics
VYNE
$8.09M
$6.9M 0.05%
700,000
– –
SYRS
59
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$6.85M 0.05%
574,835
– –
GTHX
60
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$6.65M 0.04%
127,236
-42,256
-25% -$2.21M
IFRX icon
61
InflaRx
IFRX
$117M
$6.14M 0.04%
178,987
-79,837
-31% -$2.74M
ACHN
62
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$6.04M 0.04%
1,639,948
-303,672
-16% -$1.12M
ARWR icon
63
Arrowhead Research
ARWR
$3.84B
$5.9M 0.04%
+307,496
New +$5.9M
ASMB icon
64
Assembly Biosciences
ASMB
$183M
$5.52M 0.04%
148,587
– –
NTLA icon
65
Intellia Therapeutics
NTLA
$1.26B
$5.51M 0.04%
192,538
-354,384
-65% -$10.1M
CCXI
66
DELISTED
ChemoCentryx, Inc.
CCXI
$5.23M 0.03%
414,029
– –
GNMX
67
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$4.86M 0.03%
3,950,419
-104,723
-3% -$129K
XLRN
68
DELISTED
Acceleron Pharma Inc.
XLRN
$4.8M 0.03%
83,900
-80,000
-49% -$4.58M
GLMD icon
69
Galmed Pharmaceuticals
GLMD
$7.07M
$4.4M 0.03%
324,094
-312,046
-49% -$4.23M
ALKS icon
70
Alkermes
ALKS
$4.95B
$4.26M 0.03%
100,251
– –
YMAB icon
71
Y-mAbs Therapeutics
YMAB
$390M
$3.98M 0.03%
+150,000
New +$3.98M
FOMX
72
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3.94M 0.03%
688,075
-802,126
-54% -$4.6M
CRNX icon
73
Crinetics Pharmaceuticals
CRNX
$3.26B
$3.76M 0.02%
+131,250
New +$3.76M
FTSV
74
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$3.73M 0.02%
250,000
– –
APLS icon
75
Apellis Pharmaceuticals
APLS
$3.51B
$3.49M 0.02%
196,078
– –
1 2
3
4 5